Tavneos Liver Injury Update: FDA Warning and Withdrawal Proposal
The FDA warned about serious Tavneos liver injuries in 2026 and later proposed withdrawing approval. Here is what patients and families should know.
-
-
Tavneos Liver Injury Update: FDA Withdrawal Push and What Patients Should Know
FDA regulators are pursuing withdrawal of Tavneos approval after serious liver injury reports. Here is what patients and families should know in July 2026.
-
AFFF (Aqueous Film Forming Foam) | Bard Powerport | Depo Provera | Dupixent | Hair Relaxer | Nec Baby Formula | Paraquat | Roundup | Spinal Cord Stimulator | Talcum Powder | Tavneos
Mass Tort Litigation Update: July 2026
Mid-2026 is one of the busiest stretches in recent mass tort history: two new MDLs formed in a single week in June, the Supreme Court reshaped the Roundup litigation, and the FDA moved to withdraw an approved drug from the market. Here is where the major dockets stand as of July 7, 2026. New MDLs:…
